TARS1 — Threonyl-tRNA Synthetase 1

TARS1 — Threonyl-tRNA Synthetase 1

<div class="infobox infobox-gene">
<div class="infobox-header">TARS1 — Threonyl-tRNA Synthetase 1</div>

Overview

TARS1 (Threonyl-tRNA Synthetase 1) is a human gene encoding threonyl-tRNA synthetase (ThrRS), an essential aminoacyl-tRNA synthetase that catalyzes the attachment of threonine to its cognate tRNA. This enzyme is critical for protein synthesis during translation. Beyond its canonical role in translation, threonyl-tRNA synthetase has been discovered to have diverse extra-translational functions including regulation of angiogenesis, cell migration, immune responses, and neuronal development. This page covers the gene's molecular function, disease associations, expression patterns, and emerging research on its role in neurodegeneration.

TARS1 — Threonyl-tRNA Synthetase 1

<div class="infobox infobox-gene">
<div class="infobox-header">TARS1 — Threonyl-tRNA Synthetase 1</div>

Overview

TARS1 (Threonyl-tRNA Synthetase 1) is a human gene encoding threonyl-tRNA synthetase (ThrRS), an essential aminoacyl-tRNA synthetase that catalyzes the attachment of threonine to its cognate tRNA. This enzyme is critical for protein synthesis during translation. Beyond its canonical role in translation, threonyl-tRNA synthetase has been discovered to have diverse extra-translational functions including regulation of angiogenesis, cell migration, immune responses, and neuronal development. This page covers the gene's molecular function, disease associations, expression patterns, and emerging research on its role in neurodegeneration.

<table class="infobox-table">
<tr><th>Gene Symbol</th><td>TARS1</td></tr>
<tr><th>Full Name</th><td>Threonyl-tRNA Synthetase 1</td></tr>
<tr><th>Chromosomal Location</th><td>5p13.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[6897](https://www.ncbi.nlm.nih.gov/gene/6897)</td></tr>
<tr><th>OMIM</th><td>[187960](https://www.omim.org/entry/187960)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000139921](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000139921)</td></tr>
<tr><th>UniProt</th><td>[Q9P2D0](https://www.uniprot.org/uniprotkb/Q9P2D0/entry)</td></tr>
<tr><th>Protein Length</th><td>724 amino acids</td></tr>
<tr><th>Protein Class</th><td>Aminoacyl-tRNA synthetase, class II</td></tr>
<tr><th>Associated Diseases</th><td>Charcot-Marie-Tooth disease, neurodevelopmental disorders, early-onset epileptic encephalopathy, hereditary spastic paraplegia</td></tr>
</table>
</div>

Summary

TARS1 encodes threonyl-tRNA synthetase 1, a class II aminoacyl-tRNA synthetase that catalyzes the ATP-dependent attachment of threonine to tRNA^Thr. This reaction is essential for the fidelity and efficiency of protein synthesis. ThrRS is one of several aminoacyl-tRNA synthetases that have been shown to have "moonlighting" functions beyond translation, including regulation of transcription, RNA splicing, cell signaling, angiogenesis, and immune responses. In the nervous system, TARS1 is expressed in neurons and glial cells, and pathogenic variants cause peripheral neuropathies and neurodevelopmental disorders. The enzyme's role in neuronal survival and axonal maintenance makes it a subject of interest for understanding mechanisms of neurodegeneration.

Molecular Function

Canonical tRNA Aminoacylation

Threonyl-tRNA synthetase (ThrRS) catalyzes the following two-step reaction:

The enzyme recognizes its tRNA through multiple identity elements, including the discriminator base A73, the anticodon nucleotides G34, U35, and U36, and base pairs in the acceptor stem. Human ThrRS contains N-terminal and C-terminal extensions that participate in dimerization and contribute to its regulatory functions.

Structural Features

Human ThrRS has a modular structure consisting of:

• N-terminal domain: Contains the editing site that clears mischarged amino acids
• Core catalytic domain: Class II synthetase fold with the characteristic KMSKS loop
• C-terminal domain: Involved in dimerization and extra-translational functions
• Appendage domains: Include sequences for nuclear localization and protein-protein interactions

Extra-Translational Functions

Beyond translation, threonyl-tRNA synthetase has several important non-canonical roles:

Disease Associations

Charcot-Marie-Tooth Disease

TARS1 mutations have been identified as causative for Charcot-Marie-Tooth disease (CMT), the most common inherited peripheral neuropathy. CMT caused by TARS1 variants is typically classified as CMT type 2 (axonal CMT) or intermediate CMT. The disease manifests as:

• Distal muscle weakness and atrophy
• Sensory loss
• Decreased or absent deep tendon reflexes
• Foot deformities (pes cavus, hammertoes)
• Reduced nerve conduction velocities in some cases

Neurodevelopmental Disorders

Biallelic TARS1 mutations cause a syndrome characterized by:

• Global developmental delay
• Intellectual disability
• Speech delay
• Microcephaly
• Epilepsy
• Dysmorphic features

Early-Onset Epileptic Encephalopathy

De novo missense mutations in TARS1 have been reported in individuals with early-onset epileptic encephalopathy, including Ohtahara syndrome and West syndrome. The seizures in these cases are often refractory to treatment and associated with severe developmental impairment.

Hereditary Spastic Paraplegia

Specific TARS1 variants cause pure hereditary spastic paraplegia (HSP), characterized by progressive lower limb spasticity and weakness due to degeneration of corticospinal tract neurons. This suggests that TARS1 function is particularly important for upper motor neuron survival.

Expression Pattern

Threonyl-tRNA synthetase is ubiquitously expressed, reflecting its essential role in protein synthesis. In the nervous system:

• Neurons: High expression in cell bodies and axons of both central and peripheral neurons
• Astrocytes: Moderate expression
• Oligodendrocytes: Present but lower levels
• Schwann cells: High expression in peripheral nervous system

Role in Neurodegeneration

While TARS1 is not classically considered a neurodegeneration gene, several lines of evidence suggest it may contribute to neurodegenerative processes:

Impaired Protein Synthesis in Axons

Neurons have particularly high requirements for protein synthesis due to their elongated axons and complex dendritic arbors. Local translation in axons is essential for synaptic plasticity, axonal maintenance, and response to injury. TARS1 mutations may impair this process, leading to axonal degeneration.

Mitochondrial Dysfunction

Some TARS1 variants affect mitochondrial function, possibly through impaired mitochondrial tRNA charging or disruption of the interactions between cytosolic and mitochondrial translation systems. Mitochondrial dysfunction is a common theme in many neurodegenerative diseases.

Connections to Alzheimer's and Parkinson's Disease

Although direct evidence linking TARS1 to [Alzheimer's disease](/diseases/alzheimers-disease) or [Parkinson's disease](/diseases/parkinsons-disease) is limited, the broader class of aminoacyl-tRNA synthetases has been implicated in neurodegeneration:

• Mutations in other aminoacyl-tRNA synthetases cause hereditary peripheral neuropathies
• Some synthetases are involved in stress granule formation and can influence protein aggregation
• The integrated stress response involves changes in translation that may affect aminoacyl-tRNA synthetase function

Interaction Network

TARS1 interacts with several proteins relevant to neuronal function:

| Interaction Partner | Function |
|-------------------|----------|
| EEF1A1 | Translation elongation factor |
| tRNA^Thr | Substrate for aminoacylation |
| Importin | Nuclear import |
| VEGF | Pro-angiogenic signaling |
| Ribosomal proteins | Translation machinery |

Research Findings

Key publications on TARS1 and threonyl-tRNA synthetase:

• Gene therapy to restore normal TARS1 expression
• Small molecules to enhance residual aminoacylation activity
• Supportive care for neurological symptoms

Animal Models

Mouse models with Tars1 knockout are embryonic lethal, demonstrating the essential nature of this gene. Heterozygous knockout mice show subtle deficits in neural development. Zebrafish models have been used to study TARS1 function in neuronal development and have revealed defects in axon guidance in TARS1 morphants.

Clinical Relevance

Genetic Testing

TARS1 can be included in panels for hereditary neuropathy and neurodevelopmental disorders. Whole exome sequencing has identified TARS1 as a causative gene in some cases of apparently sporadic CMT and early-onset encephalopathy.

Therapeutic Considerations

Currently, treatment is supportive and includes:

• Physical and occupational therapy
• Orthopedic interventions for foot deformities
• Anti-epileptic drugs for seizures
• Developmental support services

See Also

• [Charcot-Marie-Tooth disease](/diseases/charcot-marie-tooth-disease) — inherited peripheral neuropathy
• [Hereditary spastic paraplegia](/diseases/hereditary-spastic-paraplegia) — upper motor neuron degeneration
• [Aminoacyl-tRNA synthetases](/proteins/aminoacyl-trna-synthetases) — enzyme family overview
• [Protein synthesis machinery](/mechanisms/protein-synthesis) — translation pathway
• [Neurodevelopmental disorders](/diseases/neurodevelopmental-disorders) — related conditions

External Links

• [NCBI Gene: TARS1](https://www.ncbi.nlm.nih.gov/gene/6897)
• [UniProt: Q9P2D0](https://www.uniprot.org/uniprotkb/Q9P2D0/entry)
• [Ensembl: ENSG00000139921](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000139921)
• [OMIM: 187960](https://www.omim.org/entry/187960)
• [ClinVar: TARS1 variants](https://www.ncbi.nlm.nih.gov/clinvar/?term=TARS1)

References